July 10, 2024
IAVI signs lease on new Vaccine Design and Development Lab in Jersey City, NJ
New life sciences building to welcome IAVI’s emerging infectious disease vaccine research team
IAVI is pleased to announce that we have signed a lease on a new Vaccine Design and Development Lab (DDL) space in Jersey City, NJ. Construction has already begun on the 29,782 sq. ft. space within a lab-ready life sciences building at 95 Greene Street and is slated for completion in early 2025.
The DDL is one of the world’s leading vaccine research and development labs and serves as the preclinical development hub for IAVI’s emerging infectious disease vaccine portfolio. The team of 25 scientists and researchers is currently located at the Brooklyn Army Terminal in New York City.
“This upgraded, fit-for-purpose lab space is tailored to the DDL’s unique infrastructure needs as a leader in vaccine R&D and in global health research,” says Christopher L. Parks, Ph.D., associate vice president of viral vaccines and head of the IAVI DDL.
Read the full announcement issued by IAVI’s local real estate partner CBRE.